Article Text
Correspondence
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab
Statistics from Altmetric.com
Footnotes
Contributors EC wrote the article, BF supervised the work, BF, FF, SV and DB conceived the protocol scheme, EB, LV, SS, MAM.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Provenance and peer review Not commissioned; internally peer reviewed.